ArticleTargeted oncology2023

Analysis of Anti-Angiogenesis-Related Adverse Events Associated with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors (VEGFR-TKIs) in Patients with Metastatic Renal Cell Carcinoma.

Nuri Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.